Literature DB >> 10923993

The AS/AGU rat: a spontaneous model of disruption and degeneration in the nigrostriatal dopaminergic system.

A P Payne1, J M Campbell, D Russell, G Favor, R G Sutcliffe, N K Bennett, R W Davies, T W Stone.   

Abstract

The AS/AGU rat provides an alternative to experimentally produced laboratory models of basal ganglia disorders. This mutant is characterised by disturbances of movement including clumsy gait, whole body tremor, rigidity and difficulty in initiating movement. From an early age, there is a profound depletion of extracellular dopamine in the dorsal caudate-putamen as measured via in vivo microdialysis; levels are only 10-20% of those found in the parent Albino Swiss (AS) strain. Subsequently a depletion of whole tissue dopamine levels occurs and, later still, loss of dopaminergic cells in the substantia nigra pars compacta. The dysfunction in movement and the nigrostriatal dopaminergic system are clearly linked, since movement can be ameliorated by L-DOPA administration. Furthermore, there are depletions in glucose utilisation in several regions of the basal ganglia circuitry, including the substantia nigra pars compacta, the subthalamic nucleus and the ventrolateral thalamus. The AS/AGU rat represents a unique opportunity to investigate the intrinsic factors controlling the integrity of dopaminergic systems and the recent successful positional cloning of the agu gene will allow the molecular mechanisms underlying this interesting phenotype to be analysed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10923993      PMCID: PMC1468103          DOI: 10.1046/j.1469-7580.2000.19640629.x

Source DB:  PubMed          Journal:  J Anat        ISSN: 0021-8782            Impact factor:   2.610


  17 in total

Review 1.  Cytotoxic and genotoxic potential of dopamine.

Authors:  A H Stokes; T G Hastings; K E Vrana
Journal:  J Neurosci Res       Date:  1999-03-15       Impact factor: 4.164

2.  A comparison of neurological, metabolic, structural, and genetic evaluations in persons at risk for Huntington's disease.

Authors:  S T Grafton; J C Mazziotta; J J Pahl; P St George-Hyslop; J L Haines; J Gusella; J M Hoffman; L R Baxter; M E Phelps
Journal:  Ann Neurol       Date:  1990-11       Impact factor: 10.422

3.  Reactive dopamine metabolites and neurotoxicity: implications for Parkinson's disease.

Authors:  T G Hastings; D A Lewis; M J Zigmond
Journal:  Adv Exp Med Biol       Date:  1996       Impact factor: 2.622

4.  Large segmental differences in the spinal projections to the periaqueductal gray in the cat.

Authors:  L J Mouton; V G VanderHorst; G Holstege
Journal:  Neurosci Lett       Date:  1997-11-28       Impact factor: 3.046

5.  Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones.

Authors:  D G Graham
Journal:  Mol Pharmacol       Date:  1978-07       Impact factor: 4.436

6.  Neostriatal dopamine depletion and locomotor abnormalities due to the Albino Swiss rat agu mutation.

Authors:  J M Campbell; A P Payne; D P Gilmore; J E Byrne; D Russell; J McGadey; D J Clarke; R W Davies; R G Sutcliffe
Journal:  Neurosci Lett       Date:  1996-08-09       Impact factor: 3.046

7.  Parkinson disease: a new link between monoamine oxidase and mitochondrial electron flow.

Authors:  G Cohen; R Farooqui; N Kesler
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

8.  Optimized protocols for typing 75 microsatellite loci in AS, PVG, F344, and BN rats.

Authors:  P Shiels; M B Durán Alonso; A O Davidson; R P Heeley; A F Dominiczak; A P Payne; R W Davies; R G Sutcliffe
Journal:  Mamm Genome       Date:  1995-03       Impact factor: 2.957

9.  Modification of dopamine transporter function: effect of reactive oxygen species and dopamine.

Authors:  S B Berman; M J Zigmond; T G Hastings
Journal:  J Neurochem       Date:  1996-08       Impact factor: 5.372

10.  Neuroanatomical characterization of a new mutant rat with dopamine depletion in the substantia nigra.

Authors:  D J Clarke; A P Payne
Journal:  Eur J Neurosci       Date:  1994-05-01       Impact factor: 3.386

View more
  1 in total

Review 1.  The genetics of Parkinson's disease.

Authors:  Kah Leong Lim; Valina L Dawson; Ted M Dawson
Journal:  Curr Neurol Neurosci Rep       Date:  2002-09       Impact factor: 5.081

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.